AbbVie Reports Third-Quarter 2025 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 falls from record high as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
AbbVie (ABBV) Tops Q3 EPS by 8c, Beats on Revenue; Offers FY25 EPS Guidance
October 31, 2025 7:50 AM EDTAbbVie (NYSE: ABBV) reported Q3 EPS of $1.86, $0.08 better than the analyst estimate of $1.78. Revenue for the quarter came in at $15.78 billion versus the consensus estimate of $15.58 billion.
GUIDANCE:
AbbVie sees FY2025 EPS of $10.61-$0.65, versus the consensus of $10.86.
For earnings history and earnings-related data on AbbVie (ABBV) click here.
... More